Indian Pharmacopoeia 2026

• India has achieved a historic milestone in strengthening the quality and safety of healthcare services.

• For the first time, official quality standards specifically for blood and blood components have been established in the Indian Pharmacopoeia (IP) 2026.

• With this initiative, India has become the first country in the world to include specific standards for blood and blood components in its pharmacopoeia.

• The 10th edition of the Indian Pharmacopoeia was launched by Jagat Prakash Nadda in New Delhi on January 2, 2026.

• This move will play a crucial role in ensuring the quality, safety, and reliability of blood, while also further strengthening the country's healthcare system.

• What is the Indian Pharmacopoeia?

• Published by the Indian Pharmacopoeia Commission, the Indian Pharmacopoeia is a compendium of official quality standards for medicines and related therapeutic substances in India.

• It lays down the necessary criteria to ensure the identity, purity, potency, and quality of medicines and medical products.

• This document is considered the cornerstone of safe and effective healthcare services in the country.